SFUNY
Fang Holdings Ltd
$1.00
-52.72%
No data for this timeframe.
Vol
SEC Reports3
Exchange OTC·Sector Services-Computer Processing & Data Preparation·Inc. E9·CIK 0001294404·Prev Close $2.12
Recent Activity
Jun 9, 2026
SEC
Fang Holdings Ltd filed a 6-K confirming that a special cash distribution from a settled derivative lawsuit will be paid
6-K — Impact 2/10
May 15, 2026
SEC
Fang Holdings announced the resignation of independent director Howard Huyue Zhang for personal reasons, effective May 1
6-K — Impact 2/10
May 8, 2026
SEC
Fang Holdings announced the appointment of Qifang Liu as an independent director and audit committee member, effective M
6-K — Impact 2/10
Analyst Ratings
0Strong Buy
0Buy
2Hold
3Sell
3Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 25, 2019 | Bank of America | MAINTAIN | Underperform |
| Feb 19, 2019 | Bank of America | DOWNGRADE | Buy → Underperform |
| Dec 3, 2018 | Credit Suisse | DOWNGRADE | Neutral → Underperform |
| Aug 29, 2018 | Credit Suisse | DOWNGRADE | Outperform → Neutral |
| Aug 29, 2018 | JP Morgan | MAINTAIN | Neutral → Neutral |
Latest Reports
NEUTRAL
6-K
2/10
Fang Holdings Ltd filed a 6-K confirming that a special cash distribution from a settled derivative lawsuit will be paid
Jun 9, 2026
NEUTRAL
6-K
2/10
Fang Holdings announced the resignation of independent director Howard Huyue Zhang for personal reasons, effective May 1
May 15, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 2.0/10.
NEUTRAL
6-K
2/10
Fang Holdings Ltd filed a 6-K confirming that a special cash distribution from a settled derivative
Jun 9, 2026
NEUTRAL
6-K
2/10
Fang Holdings announced the resignation of independent director Howard Huyue Zhang for personal reas
May 15, 2026
NEUTRAL
6-K
2/10
Fang Holdings announced the appointment of Qifang Liu as an independent director and audit committee
May 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jun 2019): 0% buy across 8 analysts — 0 strong buy, 0 buy, 2 hold, 3 sell, 3 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2020-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2020-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
15 analyst firms have rated this stock: 4 upgrades, 17 downgrades, 8 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 25, 2019 | Bank of America | MAINTAIN | — | Underperform |
| Feb 19, 2019 | Bank of America | DOWNGRADE | Buy | Underperform |
| Dec 3, 2018 | Credit Suisse | DOWNGRADE | Neutral | Underperform |
| Aug 29, 2018 | Credit Suisse | DOWNGRADE | Outperform | Neutral |
| Aug 29, 2018 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Apr 18, 2017 | Benchmark | INITIATE | — | Hold |
| Feb 24, 2017 | Morgan Stanley | DOWNGRADE | Overweight | Equal-Weight |
| Dec 14, 2016 | Deutsche Bank | DOWNGRADE | Hold | Sell |
| Nov 30, 2016 | JP Morgan | MAINTAIN | — | Neutral |
| Nov 29, 2016 | Nomura | DOWNGRADE | Buy | Reduce |
| Aug 26, 2016 | CLSA | DOWNGRADE | Underperform | Sell |
| Aug 26, 2016 | CLSA | DOWNGRADE | Neutral | Sell |
| Aug 10, 2016 | Nomura | MAINTAIN | — | Buy |
| Jun 7, 2016 | Brean Capital | INITIATE | — | Hold |
| Mar 21, 2016 | Morgan Stanley | UPGRADE | Equal-Weight | Overweight |
| Nov 30, 2015 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Oct 19, 2015 | CLSA | DOWNGRADE | Buy | Outperform |
| Aug 10, 2015 | CLSA | DOWNGRADE | Buy | Outperform |
| Jun 22, 2015 | Macquarie | UPGRADE | Neutral | Outperform |
| Jun 22, 2015 | Barclays | INITIATE | — | Overweight |
| May 21, 2015 | Brean Capital | DOWNGRADE | Buy | Hold |
| May 12, 2015 | Deutsche Bank | DOWNGRADE | Buy | Hold |
| Feb 4, 2015 | JP Morgan | UPGRADE | Neutral | Overweight |
| Nov 8, 2014 | Morgan Stanley | MAINTAIN | — | Overweight |
| Nov 7, 2014 | Brean Capital | MAINTAIN | — | Buy |
| Nov 3, 2014 | TH Capital | DOWNGRADE | Buy | Hold |
| Aug 8, 2014 | Macquarie | MAINTAIN | — | Neutral |
| Jun 16, 2014 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Jun 14, 2014 | JP Morgan | MAINTAIN | — | Neutral |
| Jun 12, 2014 | Deutsche Bank | DOWNGRADE | Buy | Hold |
| Apr 16, 2014 | Goldman Sachs | UPGRADE | Neutral | Buy |
| Apr 2, 2014 | Brean Capital | INITIATE | — | Buy |
| Mar 10, 2014 | Morgan Stanley | INITIATE | — | Overweight |
| Nov 15, 2013 | Credit Suisse | INITIATE | — | Outperform |
| Nov 8, 2013 | Citigroup | MAINTAIN | — | Buy |
| Aug 30, 2013 | JP Morgan | INITIATE | — | Overweight |
| Apr 4, 2013 | Glaucus Research | INITIATE | — | — |
| Apr 3, 2013 | Deutsche Bank | MAINTAIN | — | Buy |
| Feb 11, 2013 | Citigroup | MAINTAIN | — | Buy |
| Jan 28, 2013 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Jan 9, 2013 | Bank of America | MAINTAIN | — | Buy |
| Dec 10, 2012 | Bank of America | MAINTAIN | — | Buy |
| Nov 12, 2012 | Bank of America | MAINTAIN | — | Buy |
| Nov 12, 2012 | Goldman Sachs | MAINTAIN | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | 0 | 0 | 2 | 3 | 3 | 0% | |
| Nov 1, 2021 | 0 | 0 | 2 | 3 | 3 | 0% | |
| Oct 1, 2021 | 0 | 1 | 2 | 3 | 3 | 11% | |
| Sep 1, 2021 | 0 | 1 | 2 | 3 | 3 | 11% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.